Daily Stock Opinions and Ratings

Latest Stock Buy or Sell? Make More Informed Decisions!

Today, David Driscoll commented about whether ATD-T, LVMUY-OTC, LFUS-Q, SAP-T, STN-T, MKTX-Q, UN-N, BABA-N, BAM-N, CSU-T, RY-T, NVO-N, TMO-N, NTR-T, CB-N, ALFVY-OTC, MRU-T are stocks to buy or sell.

Page 1/4

COMMENT

Investors are in for large swings in the market as over-valued stocks are sold. Rising interest rates will negatively affect small cap + tech stocks. Companies that need to raise capital will suffer.

COMMENT

Investors can protect themselves from rising interest rates by making a plan, diversifying globally and checking emotions at the door. Don't take large bets and avoid owning ETF's in tech sector. Good time to make a list of quality stocks to buy when March interest rate increase is announced.

COMMENT

Believes supply shortage of oil will result in boom. If buying oil stocks, remember that for every oil boom, there will be a bust. Good to remember that oil stocks are very risky.

TOP PICK

Believes company is very predictable which results in consistent earnings. Company is a good hedge against volatility in the market. Ability for company to raise dividend is a major strength.

TOP PICK

Believes company is good bet for investors looking for carbon removal technology. Drop in stock price has created a good opportunity to buy. Company generates a lot of free cash flow.

TOP PICK

Believes it is a great time to be in the insurance industry. Every 1% rise in interest rates = additional $1.2 billion income for the company. Expectation is for price increases (10%) at all insurance companies. Very good credit rating.

PAST TOP PICK

(A Top Pick Feb 10/21, Up 34%) Thinks company has had a good return in an over-valued market. Rising commodity prices have helped company. Demands for seeds will only increase. Expectation is for another dividend increase. Two previous exiting CEO's is a negative aspect.

PAST TOP PICK

(A Top Pick Feb 10/21, Up 23%) Believes company has unique value proposition of laboratory testing + product manufacturing. Company has been very active in making acquisitions. No material debt as a result of large free cash flow. Revenue growth will slow as Covid-19 reduces.

PAST TOP PICK

(A Top Pick Feb 10/21, Up 46%) Believes company is leading insulin producer for diabetics. Revenues outside USA are increasing. Above average financial results from previous quarter was rewarded by market. Rising diabetes levels in society will be good for company. Company has very little debt and is looking at other products.

BUY

Rising interest rates will improve net interest margins (spread between mortgages issued and deposits taken). Dividend increases have occurred across the industry. Well diversified business that has operations in USA + globally. Avoid buying too many banking stocks as exposes investor to sector risk.

DON'T BUY

Many tech sector companies trading at extreme valuations. Even well run/profitable companies will be negatively affected by rising interest rates. Company has grown large which makes it hard to grow. Not a good time to buy into the tech sector.

HOLD

Believes company is a well run however, not a good time to buy. Rising interest rates will negatively affect private equity as it is hard to raise capital. Not buying shares until clarity on interest rate increase. Stock is over valued.

DON'T BUY

Believes company has a problem with not being listed in the US market. Not enough investors to push value of stock up. Chinese government has unpredictable influence on company. Far too risky to invest in company. Not a good stock for long term investors.

BUY

Company is good as it provides quality products that are globally diversified. Middle management being reduced is good for the business. Looking for an increase in the dividend. As Covid-19 ends, believes company will strengthen.

BUY ON WEAKNESS

As interest rates increase and stock volatility goes up, more trading will occur on the company's platform. Company has good financial metrics. Believes company is over valued at current prices. Wait for market correction.

Most Recent Experts

Stockchase Insights

5i Research

John Ewing

Ewing Morris Investment Partners

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Rebecca Teltscher

Newhaven Asset Management

Rick Rule

Rule Investment Media

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Latest Stock Buy or Sell? Make More Informed Decisions!

A Comment -- General Comments From an Expert(A Commentary)

A Comment -- General Comments From an Expert(A Commentary)

A Comment -- General Comments From an Expert(A Commentary)

Metro Inc (A)(MRU-T)

Alfa Laval AB(ALFVY-OTC)

Chubb Limited(CB-N)

Nutrien Ltd.(NTR-T)

Thermo Fisher Scientific(TMO-N)

Novo-Nordisk(NVO-N)

Royal Bank(RY-T)

Constellation Software Inc.(CSU-T)

Brookfield Asset Management Inc.(BAM-N)

Alibaba Group Holding(BABA-N)

Unilever NV(UN-N)

MarketAxess (MKTX-Q)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Stockchase Insights

John Ewing

The Panic-Proof Portfolio (Stockchase Research)

Rebecca Teltscher

Rick Rule